☆ 4.5 Article

International nonproprietary names for monoclonal antibodies: an evolving nomenclature system

MABS (2022)

International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety

James S. Robertson et al.

Summary: International Nonproprietary Names (INN) are standardized naming conventions assigned by the World Health Organization (WHO) to ensure global recognition of pharmaceutical substances, facilitating safe prescribing and pharmacovigilance.

VACCINE (2022)

添加到收藏夹

Review Cell & Tissue Engineering

The harmonization of World Health Organization International Nonproprietary Names definitions for cell and cell-based gene therapy substances: when a name is not enough

Ursula Loizides et al.

Summary: The World Health Organization assigns International Nonproprietary Names (INN) to pharmaceutical substances to ensure global recognition. Unique names are particularly important for advanced therapy medicinal products, which cannot be defined by chemical nomenclature. Textual definition paragraphs are used to describe their characteristics, contributing to pharmacovigilance and patient safety.

CYTOTHERAPY (2021)

添加到收藏夹

Review Biochemical Research Methods